Lattice Biologics Ltd. (LBLTF)

USD 0.0

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - 2.46 Million 2.18 Million 1.15 Million
Cost of Revenue - - - 1.44 Million 1.24 Million 613.88 Thousand
Gross Profit - - - 1.02 Million 942.76 Thousand 541.15 Thousand
Operating Expenses - - - 1.28 Million 1.52 Million 2.02 Million
Selling, General and Administrative Expenses - - - 1.13 Million 1.37 Million 1.87 Million
Research and Development Expenses - - - - 6476.00 2185.00
Other Expenses - - - -125.53 Thousand 76.05 Thousand 44.57 Thousand
Cost and Expenses - - - 2.72 Million 2.77 Million 2.63 Million
Operating Income - - - -335.87 Thousand -564.55 Thousand -1.32 Million
Interest Expense - - - 1.04 Million 544.26 Thousand 467.02 Thousand
Income Tax Expense - - - 914.95 Thousand 620.31 Thousand 511.6 Thousand
Earnings before Tax - - - -1.48 Million -1.01 Million -1.23 Million
Net Income - - - -1.48 Million -1.01 Million -1.23 Million
Earnings Per Share Basic - - - -0.01 -0.01 -0.01
Earnings Per Share Diluted - - - -0.01 -0.01 -0.01
Weighted Average Shares Outstanding - - - 102.57 Million 93.45 Million 93.45 Million
Weighted Average Shares Outstanding (Diluted) - - - 102.57 Million 93.45 Million 93.45 Million
Gross Margin - - - 0.41 0.43 0.47
EBIT Margin - - - -0.00 -0.14 -1.07
Profit Margin - - - -0.60 -0.46 -1.07
EBITDA - - - -61.69 Thousand -264.15 Thousand -559.03 Thousand
Earnings Before Tax Margin - - - -0.14 -0.26 -1.15

Income Statement Charts